{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T12:17:55Z","timestamp":1795177075986,"version":"4.10.3"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"49","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1097\/md.0000000000008841","type":"journal-article","created":{"date-parts":[[2017,12,7]],"date-time":"2017-12-07T02:43:10Z","timestamp":1512614590000},"page":"e8841","source":"Crossref","is-referenced-by-count":17,"title":["Characteristics of culture-positive invasive pulmonary aspergillosis in patients with hematologic diseases"],"prefix":"10.1097","volume":"96","author":[{"given":"Sung-Yeon","family":"Cho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Gun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Ki","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyo-Jin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun Hee","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Mi","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Hyun","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Hong","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeon-Joon","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Wook","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-38-20210226","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1439-0507.2008.01642.x","article-title":"Aspergillus flavus: an emerging non-fumigatus Aspergillus species of significance","volume":"52","author":"Krishnan","year":"2009","journal-title":"Mycoses"},{"key":"R2-38-20210226","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1086\/421950","article-title":"Infections due to Aspergillus terreus: a multicenter retrospective analysis of 83 cases","volume":"39","author":"Steinbach","year":"2004","journal-title":"Clin Infect Dis"},{"key":"R3-38-20210226","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s11046-014-9775-z","article-title":"Antifungal susceptibility profile of cryptic species of Aspergillus","volume":"178","author":"Alastruey-Izquierdo","year":"2014","journal-title":"Mycopathologia"},{"key":"R4-38-20210226","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s11046-014-9774-0","article-title":"Multi-resistant aspergillosis due to cryptic species","volume":"178","author":"Howard","year":"2014","journal-title":"Mycopathologia"},{"key":"R6-38-20210226","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1086\/339202","article-title":"Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients","volume":"34","author":"Marr","year":"2002","journal-title":"Clin Infect Dis"},{"key":"R7-38-20210226","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","article-title":"Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSC) Consensus Group","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R8-38-20210226","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3904\/kjim.2011.26.2.220","article-title":"Evidence-based guidelines for empirical therapy of neutropenic fever in Korea","volume":"26","author":"Lee","year":"2011","journal-title":"Korean J Intern Med"},{"key":"R9-38-20210226","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1093\/cid\/cir073","article-title":"Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America","volume":"52","author":"Freifeld","year":"2011","journal-title":"Clin Infect Dis"},{"key":"R10-38-20210226","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jinf.2010.06.018","article-title":"Trends in the postmortem epidemiology of invasive fungal infections at a university hospital","volume":"61","author":"Lehrnbecher","year":"2010","journal-title":"J Infect"},{"key":"R11-38-20210226","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s11046-015-9903-4","article-title":"Disseminated aspergillosis in the immunocompetent host: a case report and literature review","volume":"180","author":"Cheon","year":"2015","journal-title":"Mycopathologia"},{"key":"R12-38-20210226","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1086\/590566","article-title":"Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria","volume":"47","author":"Segal","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R13-38-20210226","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1002\/cncr.23441","article-title":"Changes in causes of death over time after treatment for invasive aspergillosis","volume":"112","author":"Wingard","year":"2008","journal-title":"Cancer"},{"key":"R14-38-20210226","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0140-6736(15)01159-9","article-title":"Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial","volume":"387","author":"Maertens","year":"2016","journal-title":"Lancet"},{"key":"R15-38-20210226","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0732-8893(03)00013-0","article-title":"Aspergillosis caused by non-fumigatus Aspergillus species: risk factors and in vitro susceptibility compared with Aspergillus fumigatus","volume":"46","author":"Torres","year":"2003","journal-title":"Diagn Microbiol Infect Dis"},{"key":"R16-38-20210226","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.diagmicrobio.2005.01.001","article-title":"Increased frequency of non-fumigatus Aspergillus species in amphotericin B- or triazole-pre-exposed cancer patients with positive cultures for Aspergilli","volume":"52","author":"Lionakis","year":"2005","journal-title":"Diagn Microbiol Infect Dis"},{"key":"R17-38-20210226","doi-asserted-by":"crossref","first-page":"S261","DOI":"10.1080\/13693780802247702","article-title":"Differences in pathogenicity and clinical syndromes due to Aspergillus fumigatus and Aspergillus flavus","volume":"47","author":"Pasqualotto","year":"2009","journal-title":"Med Mycol"},{"key":"R18-38-20210226","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1128\/AAC.48.9.3217-3225.2004","article-title":"In vitro analyses, animal models, and 60 clinical cases of invasive Aspergillus terreus infection","volume":"48","author":"Steinbach","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"R19-38-20210226","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1365-2141.2005.05763.x","article-title":"Epidemiology and outcome of infections due to Aspergillus terreus: 10-year single centre experience","volume":"131","author":"Lass-Florl","year":"2005","journal-title":"Br J Haematol"},{"key":"R20-38-20210226","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/bmt.2011.178","article-title":"ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients","volume":"47","author":"Marchetti","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"R21-38-20210226","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/mmy\/myw134","article-title":"7th Advances against aspergilllosis: basic, diagnostic, clinical and therapeutic studies","volume":"55","author":"Cramer","year":"2017","journal-title":"Med Mycol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000008841","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:43:40Z","timestamp":1620960220000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201712080-00038"}},"subtitle":["Comparison between Aspergillus fumigatus and non-fumigatus Aspergillus species"],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":20,"journal-issue":{"issue":"49","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000008841","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]}}}